AstraZeneca hands global oncology portfolio to Edelman
By Gemma O'Reilly, PR Week UK, 04 November 2009, 12:00am
Edelman has picked up a lucrative account with AstraZeneca to handle its entire global oncology portfolio.
Share this story
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.





